CalvinLDayJr.MD

Dermatology • San Antonio, TX

Dermatologic Surgery

Physician / Owner of Skin Cancer Dermatology PLLC

Join to view full profile

Dr. Day is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Day's full profile

Already have an account?

Office
7979 Broadway Ste 202
San Antonio, TX 78209
Phone+1 210-601-6502

Fax+1 210-908-9666
Is this information wrong?

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1978 - 1982
Massachusetts General HospitalResidency, Internal Medicine, 1976 - 1978
University of Texas Southwestern Medical SchoolClass of 1976

Certifications & Licensure

TX State Medical License 1982 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FASDS) American Society for Dermatologic Surgery

Publications & Presentations

PubMed

16 citations
Guidelines of care for malignant melanoma
Lynn A. Drake, Roger I. Ceilley, Raymond L. Cornelison, William L. Dobes, William Dorner, Robert W. Goltz, Charles W. Lewis, Stuart J. Salasche, Maria L. Turner, David...> ;Journal of The American Academy of Dermatology. 1993 Apr 1
8 citations
Topical toremifene: a new approach for cutaneous melanoma?
Juhani Maenpaa, Thomas P. Dooley, Gregory Wurz, John L. VandeBerg, Edward S. Robinson, Vernon Emshoff, Pirkko Sipila, Valerie J. Wiebe, Calvin L. Day, Michael DeGregorio> ;Cancer Chemotherapy and Pharmacology. 1993 Jan 1
1002 citations
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip : implications for treatment modality sele...
Dan E. Rowe, Raymond J. Carroll, Calvin L. Day> ;Journal of The American Academy of Dermatology. 1992 Jun 1
295 citations
Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma
Dan E. Rowe, Raymond J. Carroll, Calvin L. Jr. Day> ;The Journal of Dermatologic Surgery and Oncology. 1989 Apr 1
510 citations
Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up
Dan E. Rowe, Raymond J. Carroll, Calvin L. Jr. Day> ;The Journal of Dermatologic Surgery and Oncology. 1989 Mar 1
26 citations
Eruptive widespread Spitz nevi
Steven A. Smith, Calvin L. Day, Darl E. Vander Ploeg> ;Journal of The American Academy of Dermatology. 1986 Nov 1
37 citations
Prognosis of clinical stage I melanoma patients with positive elective regional node dissection
Howard K. Koh, Arthur J. Sober, Calvin L. Day, Robert A. Lew, Alfred W. Kopf, W Lamar, A Ben Cosimi, Wood Wc, Martin C. Mihm, Ronald A. Malt> ;Journal of Clinical Oncology. 1986 Aug 1
21 citations
Expression of activation antigens by T cells infiltrating basal cell carcinomas.
Francisco J. Guillen, Calvin L. Day, George F. Murphy> ;Journal of Investigative Dermatology. 1985 Sep 1
4 citations
Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death
Howard K. Koh, Arthur J. Sober, Alfred W. Kopf, Calvin L. Day, Kenneth A. McKusick, Robert A. Lew, Thomas B. Fitzpatrick> ;The Journal of Nuclear Medicine. 1984 Nov 1
100 citations
Lentigo maligna melanoma has no better prognosis than other types of melanoma.
Howard K. Koh, E Michalik, Arthur J. Sober, Robert A. Lew, Calvin L. Day, Wayne M. Clark, Martin C. Mihm, Alfred W. Kopf, M S Blois, Thomas B. Fitzpatrick> ;Journal of Clinical Oncology. 1984 Sep 1
16 citations
Cigarette smoking and malignant melanoma. Prognostic implications.
Howard K. Koh, Arthur J. Sober, Thomas B. Fitzpatrick, Calvin L. Day, Robert A. Lew> ;Cancer. 1984 Jun 1
96 citations
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness
Terence J. Harrist, Darrell S. Rigel, Calvin L. Day, Arthur J. Sober, Robert A. Lew, Arthur R. Rhodes, Matthew N. Harris, Alfred W. Kopf, Robert J. Friedman, Frederick...> ;Cancer. 1984 May 15
124 citations
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
A R Rhodes, T J Harrist, C L Day, M C Mihm Jr, T B Fitzpatrick, A J Sober> ;Journal of the American Academy of Dermatology. 1983 Oct 1
1 citations
Early death from clinical stage I melanoma.
A J Sober, C L Day Jr, T B Fitzpatrick, R A Lew, A W Kopf, M C Mihm Jr> ;The Journal of investigative dermatology. 1983 Jun 1
20 citations
Predictors of Late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis
Calvin L. Day, Martin C. Mihm, Arthur J. Sober, Matthew N. Harris, Alfred W. Kopf, Thomas B. Fitzpatrick, Robert A. Lew, Terence J. Harrist, Frederick M. Golomb, Allen...> ;Journal of The American Academy of Dermatology. 1983 Jun 1
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.
A J Sober, C L Day Jr, T B Fitzpatrick, R A Lew, A W Kopf, M C Mihm Jr> ;The Journal of investigative dermatology. 1983 Jun 1
Early death from clinical stage I melanoma.
A J Sober, C L Day Jr, T B Fitzpatrick, R A Lew, A W Kopf, M C Mihm Jr> ;The Journal of investigative dermatology. 1983 Jun 1
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.
A J Sober, C L Day Jr, T B Fitzpatrick, R A Lew, A W Kopf, M C Mihm> ;The Journal of investigative dermatology. 1983 Jun 1
17 citations
Detection of "thin" primary melanomas.
Arthur J. Sober, Calvin L. Day, Alfred W. Kopf, Thomas B. Fitzpatrick> ;CA: A Cancer Journal for Clinicians. 1983 May 1
28 citations
Multivariate analysis. Some guidelines for physicians
Robert A. Lew, Calvin L. Day, Terence J. Harrist, William C. Wood, Martin C. Mihm> ;JAMA. 1983 Feb 4
11 citations
Skin lesions suspected to be melanoma should be photographed. Gross morphological features of primary melanoma associated with metastases.
Calvin L. Day, Martin C. Mihm, Arthur J. Sober, Thomas B. Fitzpatrick, Ronald A. Malt, Alfred W. Kopf, Robert A. Lew, Terence J. Harrist> ;JAMA. 1982 Sep 3
41 citations
Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients
Calvin L. Day, Martin C. Mihm, Robert A. Lew, Alfred W. Kopf, Arthur J. Sober, Thomas B. Fitzpatrick> ;CA: A Cancer Journal for Clinicians. 1982 Mar 1
100 citations
Narrower margins for clinical stage I malignant melanoma.
Calvin L. Day, Martin C. Mihm, Arthur J. Sober, Thomas B. Fitzpatrick, Ronald A. Malt> ;The New England Journal of Medicine. 1982 Feb 25
153 citations
The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas.
Arthur R. Rhodes, Arthur J. Sober, Calvin L. Day, John W. Melski, Terence J. Harrist, Martin C. Mihm, Thomas B. Fitzpatrick> ;Journal of The American Academy of Dermatology. 1982 Feb 1
90 citations
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative...
Calvin L. Day, Robert A. Lew, Martin C. Mihm, Arthur J. Sober, Matthew N. Harris, Alfred W. Kopf, Thomas B. Fitzpatrick, T J Harrist, Frederick M. Golomb, Allen Postel...> ;Annals of Surgery. 1982 Jan 1
Join now to see all

Professional Memberships

American Society for Dermatologic Surgery - ASDS
Fellow

CalvinLDayJr.MD

Dr. Day is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.